DexCom Reports Director/Officer Changes & Compensation
Ticker: DXCM · Form: 8-K · Filed: May 13, 2025 · CIK: 1093557
| Field | Detail |
|---|---|
| Company | Dexcom INC (DXCM) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, compensation
Related Tickers: DXCM
TL;DR
DexCom filed an 8-K detailing director/officer changes and compensation arrangements.
AI Summary
DexCom, Inc. filed an 8-K on May 13, 2025, reporting events as of May 9, 2025. The filing primarily concerns the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes financial statements and exhibits.
Why It Matters
Changes in a company's board of directors and executive officers, along with details on their compensation, can signal shifts in strategy or governance that may impact investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is routine and reports on corporate governance and compensation, not immediate financial distress or significant operational changes.
Key Players & Entities
- DEXCOM INC (company) — Registrant
- May 9, 2025 (date) — Earliest event reported
- May 13, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 6340 Sequence Drive, San Diego, CA 92121 (address) — Principal Executive Offices
FAQ
What specific director or officer positions were affected by the events reported on May 9, 2025?
The filing indicates changes related to the departure of directors or certain officers, election of directors, and appointment of certain officers, but does not specify names or exact positions within this summary.
What type of compensatory arrangements are detailed in this filing?
The filing mentions 'Compensatory Arrangements of Certain Officers' but does not provide specific details on the nature of these arrangements in the provided text.
Are there any new financial statements included with this 8-K filing?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item of information.
What is the primary purpose of this Form 8-K filing for DexCom, Inc.?
The primary purpose is to report current information about significant corporate events, including changes in directors and officers, and related compensation matters.
When was DexCom, Inc. incorporated, and where are its principal executive offices located?
DexCom, Inc. was incorporated in Delaware and its principal executive offices are located at 6340 Sequence Drive, San Diego, CA 92121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding DEXCOM INC (DXCM).